Impedimed (IPD.AX) Trading Activity
Impedimed (IPD.AX) remained flat, with no change in price during the 24‑hour period ending at 09:55 PM Central Europe on Tuesday, 20 October 2026.
- Current price: AUD 0.01 per share.
- Shares outstanding: 3.7 billion.
- Market capitalization: AUD 22 million.
- Volume traded in the last 24 hours: AUD 11.9 k.
- Year‑to‑date performance: 50 % increase since the end of the previous month.
- 200‑day simple moving average: AUD 0.01.
- 52‑week high: AUD 0.05 (recorded 29 October 2025).
- 52‑week low: AUD 0.00 (recorded 23 July 2026).
Recent 24‑Hour Performance of Related Stocks
| Ticker | Current Price | % Change | Market Capitalisation |
|---|---|---|---|
| MNE.AX | AUD 0.19 | +12.12 % | AUD 25.9 million |
| RTH.AX | AUD 1.00 | +85.19 % | AUD 25.9 million |
| BMT.AX | AUD 0.09 | –3.23 % | AUD 26.1 million |
| PKY.AX | AUD 0.02 | +5.26 % | AUD 25.7 million |
| ADN.AX | AUD 0.00 | 0 % | AUD 25.7 million |
Ras (RTH.AX) – Annual General Meeting Notice Ras Technology Holdings Limited announced that its 2026 Annual General Meeting will be held on 20 November 2026 at the Executive Innovation Centre in Kingston, ACT. Shareholders may review the Notice of Meeting and proxy instructions via the company’s ASX announcement platform. Directed proxies are encouraged to be submitted by 18 November 2026. The agenda includes resolutions on the remuneration report, director elections, and approval of a placement facility. The company provides multiple submission methods—online, mail, fax, and in person—and will not dispatch physical copies unless requested.
About Impedimed
ImpediMed Ltd. is an Australian health‑care equipment and supplies company. It develops and sells non‑invasive medical devices for diagnosing and monitoring human disorders and diseases, with a particular focus on cancer survivors.
